New Anti-PD1 trials!!!!....and others....Check this site!

Clinical Trial # = NCT01621490
Phase 1 Biomarker study in advanced melanoma
BMS sponsored trial of Nivolumab at 3mg/kg every 2 weeks for 2 years, depending on response, while measuring biomarkers.
Sites actively recruiting include:  Los Angeles, Boston, New York, Portland, Nashville, Houston. 
Requirements:  No brain mets, measurable disease, etc.

Clinical Trial # = NCT01703507
Phase 1 Ipi and Whole brain or SRS in treating melanoma with brain mets
Sites actively recruiting - Thomas Jefferson University,  Philadelphia
Will soon be opening at Ohio State University

Clinical Trial # = NCT01672450
Phase 1 with Intratumoral injection of IL2 and ipi in patients with unresectable Stage III or IV
Requires accessible tumors.
Site = Salt Lake City Utah

Clinical Trial # = NCT01497808
Stratified Phase 1/2 - Dose escalation trial of SRS (stereotactic body radiotherapy) followed by ipi in metastatic melanoma.
Sites actively recruiting = Philadelphia
Only 4 of 40 slots filled per site.

Clinical Trial # = NCT01590082
Phase 1/2 - Doxycycline, Temozolomide, and Ipi in Unresectable Stage III/IV melanoma
Site = MD Anderson
Total enrollment to be 58...seems that only 20% have been filled.
(Remember that post about everything killing melanoma???  Well, doxy was on that list!)

Outside the states... Clinical Trial # = NCT01844505
Nivolumab plus ipi OR ipi alone
Sites = US sites appear to be full.  Internationally Recruiting= Canada, Italy, Netherlands, Norway, Sweden, Switzerland.  Soon to be recruiting = Brazil, Poland, Romania, Russia, South Africa, Turkey
Stage III unresectable or Stage IV, treatment naive, melanoma.
Prior anti-PD1, PDL1 or yervoy = not allowed.

Obviously each trial and site has their own particulars. Check out the link below for more trials and information!!!! Information like this gets outdated quickly!  But, the trials I cross referenced with other sites (including NIH) seem to still be enrolling.  Please....if you are interested in any of them...CALL the location indicated!

Mdlinx.com for more clinical melanoma trials